Patents by Inventor John William Lewis

John William Lewis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7964610
    Abstract: Ester derivatives of the phenolic hydroxyl group of buprenorphine can be used in the treatment of opiate dependency and/or moderate to severe pain. The esters have an enhanced bioavailability, an enhanced duration of action, and a reduced abuse potential.
    Type: Grant
    Filed: March 27, 2007
    Date of Patent: June 21, 2011
    Assignee: Reckitt Benckiser Healthcare (UK) Limited
    Inventors: John William Lewis, Christopher Bourne Chapleo
  • Publication number: 20100234412
    Abstract: Ester derivatives of the phenolic hydroxyl group of buprenorphine can be used in the treatment of opiate dependency and/or moderate to severe pain. The esters have an enhanced bioavailability, an enhanced duration of action, and a reduced abuse potential.
    Type: Application
    Filed: March 27, 2007
    Publication date: September 16, 2010
    Applicant: RECKITT BENCKISER HEALTHCARE (UK) LIMITED
    Inventors: John William Lewis, Christopher Bourne Chapleo
  • Patent number: 5953990
    Abstract: A master chart comprises a representation of various blocks (1) of color produced by suitable combinations of the base colors cyan, magenta, yellow and black (C,M,Y,K) . There are also illustrations of color prints (2) which are to be printed by a copying machine onto a sheet. For the color standardization procedure test sheets are provided onto which the images from the master chart are to be printed. These carry the same array of color blocks (1A) and picture representations (2A) but the block and color representations are offset with respect to the positioning of the corresponding blocks on the master chart. The operator compares the various color blocks against one another and make an estimation as to what adjustments are needed to the copier to ensure that a more acceptable print is achieved.
    Type: Grant
    Filed: February 4, 1998
    Date of Patent: September 21, 1999
    Assignee: Focoltone International Limited
    Inventors: Malcolm George Chalmers, John William Lewis Humphrey, Stephen Thomas Lovatt, Andre Etienne Jean Laurent Marie Pagnac
  • Patent number: 3998843
    Abstract: Compounds of the formula: ##STR1## wherein n is an integer selected from 3, 4 and 5 and R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and A represent certain specified substituent groups. The compounds are inhibitors of acetylcholinesterase. Particularly preferred compounds are cis-2-(3-hydroxyphenyl)-1-pyrrolidinocyclohexane methobromide and cis-2-(3,6-dihydroxyphenyl)-1-pyrrolidinocyclohexane methiodide.
    Type: Grant
    Filed: June 4, 1973
    Date of Patent: December 21, 1976
    Assignee: Reckitt & Colman Products Limited
    Inventors: John William Lewis, Michael John Readhead